news-medical.net/news/20220...
through-tough-brain-cells-and-treat-Parkinsone28099s-disease.aspx
"Strikingly, we induced PFFNB2 expression in the cortex, and it prevented alpha-synuclein clumps from spreading to the mouse brain's cortex, the region responsible for cognition, movement, personality and other high-order processes."
"Additional tests in mice showed that the PFFNB2 nanobody ... can disrupt and destabilize the structure of existing alpha-synuclein clumps."
""The success of PFFNB2 in binding harmful alpha-synuclein clumps in increasingly complex environments indicates that the nanobody could be key to helping scientists study these diseases and eventually develop new treatments" says Mao, associate professor of neurology.
Ramhari Kumbhar, Ph.D., co-first author, postdoctoral fellow, Johns Hopkins University School of Medicine
-------------------------------------------------------------------------------------------
There are over 130 international clinical trials going on RIGHT NOW.
So, STAY STRONG!
A 'MIRACLE CURE' is just around the corner for all of us!
Exogenous AS a driver of disease? What does “denatured protein” mean? 
Feedback from a PD research scientist in the department of Clinical Neuroscience at the University of Cambridge (UK), on PASADENA Trial...
Is everyone aware that only when 70% of our glial cells, and possibly 80%, have been destroyed, can we be diagnosed with Pd?
Why is PD Chronic and Degenerative?
Copper Leads to Protein Aggregation in Parkinson’s Disease
